A 19-year-old womanwith diabetic lipemia and maturity-onset diabetes of the young (MODY) is reported. Though her insulin secretory activity was preserved, she fell into mild diabetic ketoacidosis (DKA) and showed type V hyperlipidemia. Post-heparin plasma activity oflipoprotein lipase (LPL) was decreased even 10 days after initiating insulin injection but not deficient. The abnormalities in lipid metabolism were improved by long-term insulin treatment. Though the contribution of the genetic background to the lipid abnormalities is not clear, the characteristics of MODY in this patient including insulin secretory capacity under stress conditions such as DKA might play a role in the development of diabetic lipemia. (Internal Medicine 36: 571-574, 1997) 
Introduction
Diabetic lipemia is an abnormality in the triglyceride-rich lipoprotein metabolism which occurs in poorly controlled diabetic patients. The clearance of very low density lipoprotein (VLDL) and chylomicrons from plasma is disturbed due to decreased activity of lipoprotein lipase (LPL) which is accounted for by severe insulin deficiency (1, 2) . In contrast, maturity-onset diabetes of the young (MODY) is a form of type II diabetes mellitus, which is phenotypically noninsulin dependent (3 , 4) . Hitherto, except for insulin-dependent diabetes mellitus (IDDM) patients of MODY with diabetic ketoacidosis (DKA)no case has been reported in noninsulindependent diabetes mellitus (NIDDM)patients of MODY pedigree. Wereport here a unique patient with MODY complicated with diabetic lipemia and mild DKA.
For editorial comment, see p 535.
Case Report
A 19-year-old woman visited our hospital because of general malaise and eruption spread over her chest for a week. The patient was diagnosed as diabetes mellitus at the age of 1 1 years old, when she showed fasting hyperglycemia. Her hyperglycemia had been controlled fairly well with diet of 40 kcal/kg alone until age of 12. Then she started to receive insulin injection twice daily (from 18 U/day to 74 U/day). At the age of 18 years, by choice, she stopped the insulin injection; she lost 8 kg of body weight in the subsequent 6 months. And 15 months later, she visited our hospital because of the general malaise and the eruption spread over her chest. On admission, she was 158 cm in height and weighed 50 kg (BMI: 20.0 kg/m2). Her blood pressure was 138/74 mmHgin the supine position, and the pulse rate 70/min. Eruptive xanthoma spread on the chest and mild lipemia retinalis was observed. No other abnormality was observed physically.
Laboratory data on admission (Table 1) showed severe fasting hyperglycemia (443 mg/dl) with elevated HbAlc (16.7%). The patient had ketonuria, and markedly increased plasma levels of both 3-hydroxybutyrate (3-OHBA) and acetoacetate (AcAc). Arterial blood gas analysis showed mild metabolic acidosis. Though she had been fasting for more than 12 hours, her serumon admissionwascreamywhite and serum triglyceride as well as total cholesterol levels were extremely elevated (3 ,386 mg/dl and 638 mg/dl respectively), and appearance of the serum after 24 hours at 4°C showedthe presence of the creamy layer (chylomicron) and turbid lower layers (Fig. 1 ) .
Agarose-gel electrophoresis of her serum lipoproteins revealed the presence of broad p-band and chylomicrons. Apolipoprotein B and apolipoprotein E levels were markedly elevated, and the phenotype of apolipoprotein E was E3/E3. There was no abnormality hematologically, tests of liver function and renal function were within normal limits. Mild hyponatremia was observed probably due to severe hypertriglyceridemia. She was diagnosed as mild diabetic ketoacidosis and diabetic lipemia, therefore continuous intravenous insulin infusion (2 U/h) was initiated to improve the metabolic abnormalities due to the severe insulin deficiency. Serum total cholesterol and triglyceride levels decreased gradually, as well as the level of ketone bodies (Fig. 2) . Plasma glucose level became 293 mg/dl, and serumketone body levels were almostcontrolled (3-OHBA 41 6 jimol//, AcAc 156 jimol//) at fasting in the morning on day 2. However,abnormalities of serum lipid levels remained abnormal on day 2 (total cholesterol 416 mg/dl, triglyceride 483 mg/ dl). The serum triglyceride levels were controlled on day 53 (total cholesterol 251 mg/dl, triglyceride 1 12 mg/dl). The activity ofLPL was examined in plasma at 10 minutes after intravenous heparin injection at a dose of 30 U/kg of body weight. The LPL activity was 0.37 jumol/ml/min (our control value; mean±SD 0.50+0.06, n=10) on day 10 after admission when serum lipid levels were still elevated (total cholesterol 346 mg/dl, triglyceride 353 mg/dl); if improved to 0.53 jimol/ ml/min on day 60 when the serum total cholesterol level was 226 mg/dl and triglyceride level, 93 mg/dl. Her parents both had diabetes and her elder sister has also suffered from diabetes which was diagnosed at the age of 12 years old and has been treated with insulin (Fig. 3) . Moreover there are several other diabetic patients in this family, which suggest that genetic factors contribute to the pathogenesis of the diabetes in this patient. To assess her insulin secretory capacity, glucagon test was performed on day 65. Plasma C-peptide level was 1.3 ng/ml before the glucagon injection and 2.8 ng/ml after 6 minutes suggesting that insulin secretion was preserved in this patient. Her urinary C-peptide excretion was 5.2 Jig/day on admission, and improved to 90 Jiig/day after 60 days on insulin treatment. Serological examination revealed that islet cell antibody (ICA) at the onset of diabetes was negative in both sisters, and that glutamic acid decarboxylase (GAD) antibody in this patient was also negative. The family history and results of laboratory examinations suggest that this patient has MODY. been known that hypertriglyceridemia of over 2,000 mg/dl is occasionally (less than 1%) found in patients with severe, uncontrolled diabetes mellitus (5, 6 such as DKA (7). However, not all the diabetic patients with DKAmanifest diabetic lipemia; in the 13 DKAcases reported by Nikkila et al, the serum triglyceride levels were 234±35 mg/ dl (7). From our experience of 30 DKAcases, the triglyceride levels were approximately 300 mg/dl, except for the present case. In the 211 DKAcases reported by Fulop and Eder, 15 patients showed plasma triglyceride concentrations above 1 ,000 mg/dl and only 3 of those patients showed plasma triglyceride concentrations above 3,000 mg/dl (8) . Therefore, the pathogenesis of diabetic lipemia is not solely accounted for by the insulin deficiency, but by the same background abnormalities as in triglyceride-rich lipoprotein metabolism.
In the present case, apolipoprotein C-II for the activation of LPL and the post-heparin plasma LPL activity was not deficient in well-controlled conditions and no abnormality was found in apoE phenotype. In heterozygote of LPL deficiency proved by DNAanalysis, serum triglyceride levels are reported to be elevated slightly in usual conditions, but could be increased to more than 2,000 mg/dl under stress such as infection, pregnancy or diabetes mellitus, showing type V hyperlipidemia (9, 1 0). And Takagi et al extensively studied the clinical characteristics of subjects with LPLmutation and reported that subjects with abnormal LPL showed type IV hyperlipidemia (ll).
Therefore, it is possible that subtle abnormality in lipid metabolism in usual conditions may contribute to the diabetic lipemia of this case observed in severe insulin deficiency, though we did not determine the LPL activity in the condition of diabetic lipemia. Further investigation on LPL and other genetic abnormalities is required to clarify the exact mechanismsof diabetic lipemia seen in this case, even though this patient has normal LPL activity under good glycemic control. The pathogenesis of diabetes mellitus in this patient was influenced by genetic background since there were many diabetic patients in her pedigree. Tattersall described the characteristics ofMODYin 1975 (12) . In the recent reviews, MODY can be diagnosed by the following: the age of onset of diabetes under 25-year-old, autosomal dominant inheritance and no requirement of insulin therapy for at least 5 years after the onset of diabetes except in some cases (3, 4) . Though insulin therapy was initiated one year after the onset, this patient was not dependent on insulin for survival. This case, therefore, could be diagnosed as MODY since the age of onset was ll years old, and diabetic patients are found in more than 3 generations in her family. MODY can be also classified into three types by gene mutation at present. However, we have not examined the MODY genes, thus the exact type of MODY has not been diagnosed, and the contribution of the genetic characteristics of diabetes to the lipid abnormalities is not clear at this point. Since no other cases of DKAand of diabetic lipemia have been reported in NIDDMpatients of the MODYpedigree (except for IDDMpatients of the MODYpedigree) to our knowledge, it is likely that not only the characteristics of MODY including the insulin secretory capacity under the stress conditions but also other genetic background in lipid metabolism in the present patient might play a role in the development of diabetic lipemia. In summary, we reported a unique case with MODY complicated with DKAand diabetic lipemia. Genetic background in metabolism or MODY might contribute to the abnormal conditions.
